PodcastIntel
Sign in Get Started Free
The Immune-Mediated Inflammatory Disease Forum
The Immune-Mediated Inflammatory Disease Forum

Discussing axSpA: 52-week results from the Phase 3 BE MOBILE trials

Sep 30, 2026 · 0:20:11
Listen to Episode
✨ AI Summary
  • BE MOBILE trials analyzed 52-week data on bimekizumab for axSpA.
  • Explored potential sex-based differences in patient response to treatment.
  • Covered both non-radiographic and radiographic forms of axSpA.

Guests on This Episode

AD
Atul Deodhar
researcher · 2 podcast appearances
›
SR
Sofia Ramiro
researcher · 6 podcast appearances
›

More from The Immune-Mediated Inflammatory Disease Forum

The Immune-Mediated Inflammatory Disease Forum
Discussing RA: Impact of BMI on response to JAK inhibitors in RA
Oct 8, 2026 · 0:07:14
The Immune-Mediated Inflammatory Disease Forum
Author Interview: Doctor Elise van Mulligen, September 2026
Sep 3, 2026 · 0:21:21
The Immune-Mediated Inflammatory Disease Forum
Discussing RA: Biologic effectiveness and treatment persistence in RA
Aug 27, 2026 · 0:08:53
The Immune-Mediated Inflammatory Disease Forum
Discussing PsA: Advances in Psoriatic Arthritis Management and Treatment Safety
Aug 20, 2026 · 0:24:23
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to The Immune-Mediated Inflammatory Disease Forum and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →